Watch Ticker

Genenta Science S.p.A. American Depositary Shares

Go to Genenta Science S.p.A. American Depositary Shares Website

$3.78

0.00 (0.00%)

Live

Previous Close

$3.78

Day Range

$0 - $0

Previous Day Range

$3.7482 - $3.8

Market Cap

$67.7 million USD

Day Vol.

Previous Day Vol.

1736

Currency

USD

Primary Exchange

Nasdaq

Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

N/A - Genenta Showcases Strategic Vision at Premier Biotech Forum in Qatar

Genenta Science, a biotech company, has secured €20 million ($21.9M) in financing to expand its pipeline, including advancing its Temferon™ product candidate for metastatic Renal Cell Carcinoma. The company's brain tumor trial is also showing promising survival rates.

Related tickers: GNTA.

Read Full Article

Prnewswire - Oncology Breakthroughs: How Cancer Research Is Advancing in 2025

The article discusses recent advancements in cancer research and treatment, including promising results from clinical trials of various cancer therapies developed by companies like Oncolytics Biotech, Celcuity, Genenta Science, Sellas Life Sciences, and Amgen.

Related tickers: ONCY, CELC, GNTA, SLS, AMGN.

Read Full Article

Trending Tickers

Please sign in to view